OptiNose (NASDAQ: OPTN)
Some price data may be temporarily unavailable.
OptiNose Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
OptiNose Company Info
OptiNose, Inc. operates as a pharmaceutical company. The firm engages in the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists. Its products include the XHANCE and ONZETRA Xsail. The company was founded by Per Gisle Djupesland and Helena Kyttari Djupesland in October 2000 and is headquartered in Yardley, PA.
News & Analysis
Why Sunnova Energy, Rimini Street, and OptiNose Stocks All Dropped Today
Some stock offerings dilute -- but not all.
Here’s Why Shares of Optinose Crashed Today
A secondary offering resets the valuation of the ear, nose, and throat specialist.
Valuation
Earnings Transcripts
OptiNose, Inc. (OPTN) Q3 2020 Earnings Call Transcript
OPTN earnings call for the period ending September 30, 2020.
OptiNose, Inc. (OPTN) Q2 2020 Earnings Call Transcript
OPTN earnings call for the period ending June 30, 2020.
OptiNose, Inc. (OPTN) Q1 2020 Earnings Call Transcript
OPTN earnings call for the period ending March 31, 2020.
OptiNose, Inc. (OPTN) Q4 2019 Earnings Call Transcript
OPTN earnings call for the period ending December 31, 2019.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.